Creso Pharma Signs LOI With ImpActive For Further Growth

Creso Pharma (ASX: CPH) this morning announced that it has signed a non-binding letter of intent with that of ImpACTIVE Holdings. The LOI outlines the distribution of a suite of hemp CBD based products, CannaDOL and cannaQIX, in both Canada and the United States.

The arrangement will see both of Creso’s hemp based CBD products meant for human consumption distributed by ImpActive, which is a Canadian firm focused on reducing muscle and joint inflammation, particularly as they related to sports injuries. ImpActive itself has developed a number of CBD products focused on removing the use of narcotics or prescription pharmaceuticals for such injuries.

Under the terms of the non-binding letter of intent, both Creso and ImpActive have agreed to enter a formal commercial agreement by April 1, 2021. The commercial agreement is to determine the terms under which both CannaDOL and cannaQIX will be distributed, with Creso also to become an authorized distributor of ImpActive’s CBD based roll on products in Switzerland and Europe.

“We are very proud to enter the sports and recreational market with such a high calibre partner as ImpACTIVE. This LOI is important for Creso Pharma, as it further broadens our international footprint and provides another large market opportunity.”

Jorge Wernli, Commercial Director of Creso Pharma

The initial term of the arrangement is currently pegged at one year, with an automatic renewal for a second year.

Creso Pharma last traded at $0.20 on the ASX.


FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Red Light Holland, Creso Pharma Walk From Merger Due To COVID Headwinds

Red Light Holland (CSE: TRIP) and Creso Pharma (ASX: CPH) evidently have elected to walk...

Monday, August 30, 2021, 09:12:37 AM

Creso Pharma Sees Canadian Subsidiary Secure Numerous Purchase Orders

Creso Pharma (ASX: CPH) this morning announced that it has secured a number of new...

Thursday, February 4, 2021, 07:03:33 AM

Creso’s Canadian Subsidiary Sees $494,000 In Additional Orders

Creso Pharma (ASX: CPH) this morning announced that its Canadian subsidiary, Mernova Medicinal, has obtained...

Wednesday, February 17, 2021, 10:16:02 AM

Mernova: Creso Pharm’s Licensed Cannabis Producer – The Daily Dive feat Jack Yu

Today on the Daily Dive, we sit down with Jack Yu, managing director of Mernova...

Thursday, February 11, 2021, 01:30:00 PM

Creso Pharma Enters LOI For Product Distribution In The USA

Creso Pharma (ASX: CPH) is the latest issuer to enter the US cannabis market. The...

Monday, March 1, 2021, 07:25:54 AM